RE: Bruker , Adeptrix buy in9 Jan 2021 11:35
“ The kit is intended for the development of analytical tests that detect presence and/or measure abundance of SARS-Cov-2 and for molecular characterisation of the spike glycoprotein by mass spectrometry (MS), including protein mass measurement, disulfide bond localisation, protein glycosylation patterns and emerging viral protein mutations.”
Just a thought.... do we think this is how the U.K. is detecting all the latest mutations? We already seem to have become a world leader in this. Wonder if it’s down to BAMS with affimers rather than PCR?